precoated plates, ready to use

Timely Delivery

orders over $99.

99% Customer


360 Days

100% money back

Online Support 24/7

Secure System

Bevacizumab is a recombinant Human IgG;? monoclonal antibody specific for all human vascular endothelial growth factor A (VEGF-A) isoforms. Additionally, Bevacizumab binds to and neutralizes all human VEGF-A isoforms an bioactive proteolytic fragments, but not mouse or rat VEGF.

Intended Use:
The KRIBIOLISA Bevacizumab ELISA is used as an analytical tool for quantitative determination of Bevacizumab in serum, plasma and cell culture supernatant..

The method employs the quantitative sandwich enzyme immunoassay technique. Antibodies to Bevacizumab are pre-coated onto microwells. Samples and standards are pipetted into microwells and human Bevacizumab present in the sample are bound by the capture antibody. Then, a HRP horseradish peroxidase) conjugated anti-Bevacizumab antibody is pipetted and incubated. After washing microwells in order to remove any non-specific binding, the ready to use substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Bevacizumab in the sample. Color development is thenstopped by addition of stop solution. Absorbance is measured at 450 nm.
Product Specifications
Citations No
Pack Size 1 x 96 wells
Brand Krishgen Biosystems
Other Recommendation No
Reactivity or Species No
Made to Measure N/A